A review of 16 studies linked presurgical melatonin and zolpidem to less postoperative pain, with over 30% less opioid use in some patients.
News|Articles|June 12, 2026
How PBMs are tackling behavioral health
Author(s)Denise Myshko
Fact checked by: Cheney Gazzam Baltz
Demand for behavioral healthcare has surged, increasing costs for health plans and employers as millions of Americans deal with mental illness, substance use disorders and access challenges.
Advertisement
Advertisement
The COVID-19 pandemic exposed the cracks in America’s mental and behavioral healthcare system. At the height of the pandemic, the rates of depression and anxiety worldwide had increased by 25%, according to the World Health Organization, and 90% of adults in the U.S. believed the country was facing a mental health crisis, according to results of a
Related to this article
Prime Therapeutics' Pat Gleason, Pharm.D., outlined T1D screening gaps for plans and his priorities as incoming AMCP president.
Healthcare affordability has emerged as an issue in the Nov. 3 elections that will determine control of the Senate and the House.
Research presented at AMCP Nexus this week explores barriers to prescriptions for atopic dermatitis.
Adults newly diagnosed with narcolepsy type 1 rack up healthcare costs 5.5 times higher than people without the condition, a Takeda-funded analysis finds, even with treatments available.
Federal HIV guidelines add Bixlenvo as a switch option, back statins for adults 40 to 75 and urge clinicians to challenge payer barriers to antiretroviral therapy (ART).
Sempre Health CEO Anurati Mathur says affordability dollars should reach patients on every fill, and reversed claims show plans when they don’t.
Based on her findings, Mathur shared members in a UPMC affordability program were more adherent to heart drugs, with fewer ER visits and no significant rise in total cost of care.
Advertisement
Advertisement